Next generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Method comparison – a practical approach based on error identification
4. Review
5. Neutrophil gelatinase-associated lipocalin as a risk marker in cardiovascular disease
6. Mini Reviews
7. α-Defensin point-of-care test for diagnosis of prosthetic joint infections: neglected role of laboratory and clinical pathologists
8. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature
9. Opinion Paper
10. New issues on measurement of B-type natriuretic peptides
11. Genetics and Molecular Diagnostics
12. The SEeMORE strategy: single-tube electrophoresis analysis-based genotyping to detect monogenic diseases rapidly and effectively from conception until birth
13. General Clinical Chemistry and Laboratory Medicine
14. Determination of serum calcium levels by ⁴²Ca isotope dilution inductively coupled plasma mass spectrometry
15. The effects of dry ice exposure on plasma pH and coagulation analyses
16. Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia
17. Circulating CD89-IgA complex does not predict deterioration of kidney function in Korean patients with IgA nephropathy
18. Performance analysis of automated evaluation of Crithidia luciliae-based indirect immunofluorescence tests in a routine setting – strengths and weaknesses
19. Performance of automated digital cell imaging analyzer Sysmex DI-60
20. Reference Values and Biological Variations
21. Determination of reference intervals for urinary steroid profiling using a newly validated GC-MS/MS method
22. Reference intervals and longitudinal changes in copeptin and MR-proADM concentrations during pregnancy
23. Definition of the upper reference limit of glycated albumin in blood donors from Italy
24. Reference values of fecal calgranulin C (S100A12) in school aged children and adolescents
25. Processing-independent proANP measurement for low concentrations in plasma: reference intervals and effect of body mass index and plasma glucose
26. Cancer Diagnostics
27. Cancer sniffer dogs: how can we translate this peculiarity in laboratory medicine? Results of a pilot study on gastrointestinal cancers
28. Cardiovascular Diseases
29. NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis
30. Analytical evaluation of the new Beckman Coulter Access high sensitivity cardiac troponin I immunoassay
31. Infectious Diseases
32. Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor
33. Effects of procalcitonin testing on antibiotic use and clinical outcomes in patients with upper respiratory tract infections. An individual patient data meta-analysis
34. Acknowledgment
35. Letters to the Editor
36. Handling the altered test results of hemolyzed samples. Recommendations of the Quality, Management, Safety and Evidence Committee (CCGSE) of the Spanish Association of Medical Biopathology and Laboratory Medicine (AEBM-ML)
37. Reply to: Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor
38. Excessive hypercortisolemia due to ectopic Cushing’s syndrome requiring extending the reportable range for plasma cortisol for management
39. Heavy chain disease: our experience
40. An abnormal elevation of serum CA72-4 due to taking colchicine
41. Rivaroxaban non-responders: do plasma measurements have a place?
42. Next generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma
43. A multicenter effort to improve comparability of vitamin B6 assays in whole blood
44. PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis